Brad Everson joined HepQuant in 2009 and has served as Chief Business Development Officer since 2015. Mr. Everson is responsible for HepQuant’s Pharma Solutions business. His 20 years of experience... read more →
Paige Nardi, MBA, joined the Company in June 2023 as Vice President of Market Access, with responsibility for reimbursement, billing and market access. Ms. Nardi was Executive Director of Market... read more →
Carrie Mulherin joined HepQuant as its Chief Commercial Officer in May 2023. Ms. Mulherin brings deep experience in strategic marketing, cross-functional team management, and launch of more than 30 products.... read more →
Shailesh Chavan, MD, joined the Company in May 2023 as Chief Medical Officer. Dr. Chavan is a physician, scientist and entrepreneur focused on developing innovative therapies and diagnostics that improve... read more →
Kelly R. Pitts, PhD, joined HepQuant in April 2023. As Chief Operating Officer, Dr. Pitts is responsible for manufacturing and clinical lab operations. He most recently served as Senior Vice... read more →
Steve Helmke, PhD, joined HepQuant as Chief Scientific Officer in April 2017. Dr. Helmke was a member of the scientific team in Dr. Everson’s laboratory at the University of Colorado... read more →
Randy Dietrich is president of HepQuant. With responsibility for commercialization and capitalization, Mr. Dietrich has been one of the major financial backers of HepQuant and has been active in its... read more →
Dr. Everson founded HepQuant in 2007 and has served as Chief Executive Officer of HepQuant since its inception. He was Professor of Medicine and Director of Hepatology at the University... read more →